ANTIBODIES AGAINST SARS-COV-2 SPIKE PROTEIN

    公开(公告)号:US20220213176A1

    公开(公告)日:2022-07-07

    申请号:US17702710

    申请日:2022-03-23

    Abstract: The present disclosure provides human antibodies and fragments thereof having binding specificity to the SARS-CoV-2 spike protein's receptor binding domain (RBD). The antibodies and fragments have strong affinity and potent neutralization ability against the SARS-CoV-2 virus and various mutant forms. Also provided are trimeric antibodies which have further enhanced neutralization capabilities. The antibodies and fragments thus may be used for preventing or treating SARS-CoV-2 viral infection or detecting the presence of the virus in a sample.

Patent Agency Ranking